Clinuvel Pharmaceuticals Ltd ADR (CUVL) Stock Price, Quote & News

Company Profile

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone; and P...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9660 4900

Fax: 61 3 9660 4999

Website: www.clinuvel.com

Address:

535 Bourke Street, Level 22, Melbourne, Australia

I___I Sep. 8 at 1:43 PM

$CUVL

0 · Reply

mciuzelis Sep. 1 at 6:07 PM

$CUVL what an undiscovered gem! added here and will add much more after some exits.

0 · Reply

ArbVinnie Sep. 1 at 12:47 PM

$CUVL this is way too cheap! I'm taking advantage of low sentiment to build a position here

0 · Reply

kule04 Sep. 1 at 10:55 AM

$CUVL looking beautiful here at it's 52 week low

1 · Reply

I___I Sep. 1 at 10:54 AM

$CUVL https://youtu.be/x0FkkTOsVTQ

1 · Reply

serenityNOW Aug. 31 at 8:46 PM

$IBRX $SLS $XBI here something for the Biotech "aficionados" that might be worth taking a closer look (spoiler for the adrenaline chasers - it's long term) $CUVL

0 · Reply

Jalu06 Aug. 27 at 1:50 PM

$CUVL VLRX-001 can become a value driver. A peptide with flexible dosing can be of worth in very different aspects: - anti aging - cns diseases - photomedicine There are different markets that could be targeted: affluent costumers and pharmaceutical patients. I.e., this could be a better treatment approach for vitiligo than those implants as the efficacy might depend on the dose and the dose depends on body weight

1 · Reply

Jalu06 Aug. 26 at 4:57 PM

$CUVL waited for ages to can post at Stocktwits about my favorite stock. invested since 2019, looking forward to the times ahead. Especially the CUV105 readout could become a catalyst. A successful phase 3 readout could be a value inflection point not seen so far with clinuvel. The novel peptide delivery Methode could be interesting as well. Only 50 mio shares outstanding with low volume could lead to a huge increase in share price, like in 2021. Furthermore there are large shareholders holding for very long time. Those will not sell for 20 or 30$. Limited risk for dilution after value inflection points due to the self funding. Tomorrow clinuvel will release their annual results. Last years it wasn’t a nice day for shareholders. We will see what tomorrow brings.

1 · Reply

I___I Aug. 24 at 2:39 PM

$CUVL https://www.reddit.com/r/biotech_stocks/comments/1vwomys/cuvl_clinuvel_profitable_peptide_biotech_226m_ev/

0 · Reply

I___I Aug. 24 at 11:15 AM

$CUVL https://www.chartmill.com/news/CUVL/Chartmill-53890-Clinuvel-NASDAQCUVL-A-Quality-Investing-Screen-Standout

0 · Reply

Clinuvel Pharma FY26 Profit Slips 6%; Maintains A$0.05 Dividend; Shares Slide

Aug 27, 2026, 4:00 AM EDT - 14 days ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2026

Aug 27, 2026, 4:00 AM EDT - 14 days ago

Clinuvel Pharmaceuticals Annual report: H2 2026

Aug 27, 2026, 4:00 AM EDT - 14 days ago

Clinuvel Pharmaceuticals Earnings release: H2 2026

Aug 27, 2026, 4:00 AM EDT - 14 days ago

Clinuvel Pharmaceuticals Slides: H2 2026

Aug 27, 2026, 1:42 AM EDT - 14 days ago

A decade of profitability provides foundation for CLINUVEL's U.S. expansion

Jul 23, 2026, 12:10 AM EDT - 7 weeks ago

CLINUVEL implements strategic reorganisation to refocus on U.S. markets

Jul 20, 2026, 1:37 AM EDT - 7 weeks ago

CLINUVEL's ADS to commence trading on Nasdaq

Jul 13, 2026, 1:10 AM EDT - 1 month ago

SCENESSE® approved for EPP in Canada

Apr 24, 2026, 1:47 AM EDT - 4 months ago

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

Apr 15, 2026, 2:18 AM EDT - 4 months ago

CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026

Feb 26, 2026, 2:00 AM EST - 6 months ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2026

Feb 26, 2026, 2:00 AM EST - 6 months ago

Clinuvel Pharmaceuticals Quarterly report: H1 2026

Feb 26, 2026, 2:00 AM EST - 6 months ago

Clinuvel Pharmaceuticals Slides: H1 2026

Feb 26, 2026, 2:00 AM EST - 6 months ago

Clinuvel Pharmaceuticals Earnings release: H1 2026

Dec 7, 2025, 9:37 PM EST - 9 months ago

CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

Nov 13, 2025, 6:00 PM EST - 10 months ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

Sep 28, 2025, 10:56 PM EDT - 11 months ago

CLINUVEL to advance novel pharmaceutical formulations in preclinical program

Aug 28, 2025, 3:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2025

Aug 28, 2025, 3:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Annual report: H2 2025

Aug 28, 2025, 3:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Slides: H2 2025

Aug 28, 2025, 3:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Earnings release: H2 2025

Aug 22, 2025, 3:43 AM EDT - 1 year ago

CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist

Jun 24, 2025, 2:00 AM EDT - 1 year ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

May 7, 2025, 12:10 AM EDT - 1 year ago

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105

Mar 3, 2025, 9:17 PM EST - 1 year ago

Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Quarterly report: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Slides: H1 2025

Feb 27, 2025, 2:00 AM EST - 1 year ago

Clinuvel Pharmaceuticals Earnings release: H1 2025

Oct 15, 2024, 6:30 PM EDT - 1 year ago

Clinuvel Pharmaceuticals Transcript: AGM 2024

Oct 15, 2024, 6:30 PM EDT - 1 year ago

Clinuvel Pharmaceuticals Slides: FY 2024

Sep 30, 2024, 7:07 PM EDT - 1 year ago

CLINUVEL files Canadian New Drug Submission for SCENESSE® in EPP

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Annual report: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: H2 2024

Aug 29, 2024, 4:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2024

Jun 17, 2024, 8:39 PM EDT - 2 years ago

Afamelanotide in fair-skinned Parkinson's patients

May 1, 2024, 7:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: Investor Presentation

Mar 28, 2024, 4:25 AM EDT - 2 years ago

Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors

Mar 4, 2024, 9:38 PM EST - 2 years ago

Malibu shines a light on CLINUVEL's pioneering work in photomedicine

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2024

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2024

Feb 22, 2024, 2:00 AM EST - 2 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2024

Oct 31, 2023, 3:00 AM EDT - 2 years ago

Clinuvel Pharmaceuticals Slides: FY 2023

Oct 1, 2023, 8:00 PM EDT - 2 years ago

Clinuvel Pharmaceuticals Transcript: Status Update

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2023

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Annual report: H2 2023

Aug 29, 2023, 4:00 AM EDT - 3 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2023

Feb 28, 2023, 6:58 PM EST - 3 years ago

CLINUVEL Launches CYACÊLLE, Next Generation Solar Care

Feb 23, 2023, 8:00 PM EST - 3 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2023

Feb 23, 2023, 8:00 PM EST - 3 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2023

Feb 23, 2023, 6:14 PM EST - 3 years ago

Global SCENESSE® demand drives increased CLINUVEL revenues, earnings

Feb 1, 2023, 7:14 PM EST - 3 years ago

CLINUVEL Drug Significantly Reduces Critical UV Skin Damage in Fair-Skinned Individuals

Jan 15, 2023, 6:23 PM EST - 3 years ago

CLINUVEL Trial Results Show Drug Reduces DNA Damage

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Annual report: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2022

Aug 31, 2022, 3:30 AM EDT - 4 years ago

Clinuvel Pharmaceuticals Slides: H2 2022

May 9, 2022, 9:33 PM EDT - 4 years ago

CLINUVEL progresses vitiligo treatment program

May 3, 2022, 8:24 PM EDT - 4 years ago

Positive final results in stroke

Apr 29, 2022, 1:20 AM EDT - 4 years ago

Letter to shareholders from CLINUVEL's CEO

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H1 2022

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Quarterly report: H1 2022

Feb 23, 2022, 12:00 PM EST - 4 years ago

Clinuvel Pharmaceuticals Earnings release: H1 2022

Nov 7, 2021, 11:03 PM EST - 4 years ago

CLINUVEL Expands Pharmaceutical Portfolio

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Earnings Call Transcript: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Annual report: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Earnings release: H2 2021

Aug 25, 2021, 8:00 PM EDT - 5 years ago

Clinuvel Pharmaceuticals Slides: H2 2021

Mar 23, 2021, 8:10 PM EDT - 5 years ago

CLINUVEL expands DNA Repair Program

I___I Sep. 8 at 1:43 PM

$CUVL

0 · Reply

mciuzelis Sep. 1 at 6:07 PM

$CUVL what an undiscovered gem! added here and will add much more after some exits.

0 · Reply

ArbVinnie Sep. 1 at 12:47 PM

$CUVL this is way too cheap! I'm taking advantage of low sentiment to build a position here

0 · Reply

kule04 Sep. 1 at 10:55 AM

$CUVL looking beautiful here at it's 52 week low

1 · Reply

I___I Sep. 1 at 10:54 AM

$CUVL https://youtu.be/x0FkkTOsVTQ

1 · Reply

serenityNOW Aug. 31 at 8:46 PM

$IBRX $SLS $XBI here something for the Biotech "aficionados" that might be worth taking a closer look (spoiler for the adrenaline chasers - it's long term) $CUVL

0 · Reply

Jalu06 Aug. 27 at 1:50 PM

1 · Reply

Jalu06 Aug. 26 at 4:57 PM

1 · Reply

I___I Aug. 24 at 2:39 PM

$CUVL https://www.reddit.com/r/biotech_stocks/comments/1vwomys/cuvl_clinuvel_profitable_peptide_biotech_226m_ev/

0 · Reply

I___I Aug. 24 at 11:15 AM

$CUVL https://www.chartmill.com/news/CUVL/Chartmill-53890-Clinuvel-NASDAQCUVL-A-Quality-Investing-Screen-Standout

0 · Reply

ThedaCook628 Aug. 24 at 10:14 AM

$PEPE $BE $NKE $CUVL Pepe remains highly sentiment-driven, Bloom Energy benefits from distributed power and data-center demand, Nike is focused on brand and consumer recovery, and CUVL remains highly speculative. I'm watching crypto liquidity, power demand, retail sales, and funding.

0 · Reply

I___I Aug. 23 at 5:24 AM

$CUVL https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-03123386-3A699266&v=undefined

0 · Reply

I___I Aug. 21 at 11:05 AM

$CUVL https://www.ft.com/content/b8a4c753-ce4a-4065-9f70-85e88dd4eaf2

0 · Reply

I___I Aug. 20 at 1:02 PM

$CUVL https://us06web.zoom.us/webinar/register/WN_PtGSnsu0TCeQOSToxLrW_A#/registration

0 · Reply

Gunibald Aug. 20 at 4:33 AM

$CUVL LFG!

0 · Reply

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	0.00
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	N/A

Volume	18,800
Avg Vol	3,478
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	37%
Beta	N/A
Analysts	Strong Buy
Price Target	N/A